Healthleap

Active#11 in South Africa

Estimated valuation · Clinical AI screening · South Africa

Analyses hospital electronic health records every night to flag adult inpatients likely to have undiagnosed conditions such as malnutrition or delirium, giving care teams a morning risk list.

Healthtech›clinical AI screening healthleap.ai

Founded2022

HQCape Town

RaisedUSD 38M

Last roundSeries A · Oct 2026

Country of originSouth AfricaListed in the South Africa ranking

Where would you invest?South AfricaJurisdiction as cited by the ranking

Estimated valuation

AI · South Africa ranking

≈ USD 150MUSD 120–190M · Hundreds of M$

Hundreds of k$

Millions $

Tens of M$

Hundreds of M$

Unicorn

Decacorn

Hectocorn

Anchor: Last known equity round: Series A · USD 30M · Oct 2026
AI adjustment: None

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
South Africa · all sectors	Top 20	#11	Edition 0 · October 2026	17 Jan 2027

Rank historyOct 2026 · #11First edition: no movements yet.

Funding history

USD 38M raised in total

Date	Round	Amount	Type	Investors
Oct 2026	Series A	USD 30M	Equity	Hummingbird Ventures, Sequoia Capital

Oct 2026 , after a USD 8M seed.

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Healthleap as a PDF. It must answer at least one of these four questions, and stick to them:

AI valuation: $150MUndervalued or overvalued?

Versus competitorsHow does it compare?

Who should acquire itStrategic buyers, and why

Who should it acquireAcquisition targets, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Back Healthleap whether or not it has agreed: your intention joins the pool on Healthleap, passed to the Fundraising Desk of its country once it reaches critical mass. Backing on Uback (pronounced “you back”) means declaring an Interest (free) or an Intention (coming soon). Backing does not mean that this company is raising funds or that a shareholder is selling shares, and it is not a commitment to invest. Any deal, through a funding round or a sale by an existing shareholder, is handled by a partner desk: the Fundraising Desk of the country for a round, the Secondary Sales Desk assigned to the company for a sale.

Back Healthleap Or back healthtech in South Africa

Pool on HealthleapBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until you sign with a partner desk. If the company does not follow up, Uback invites its Backers to move their intentions to a competitor or a similar company. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run Healthleap?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Read by the AI at the next edition.

Comparable companies in South Africa

Full South Africa ranking →

Peach Payments#10Fintech › payment gatewayHundreds of M$Carry1st#12Gaming › mobile games publisher and marketplaceHundreds of M$Lula#9Fintech › SME lendingHundreds of M$Moment#13Fintech › payment infrastructureHundreds of M$

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.